The Corneal Micropocket Assay: a Model of Angiogenesis in the Mouse Eye

Overview

Journal J Vis Exp

Specialties Biology
General Medicine

Date 2014 Sep 2

PMID 25177860

Citations 16

Authors

Amy E Birsner

Ofra Benny

Robert J DAmato

Affiliations

Soon will be listed here.

Abstract

The mouse corneal micropocket assay is a robust and quantitative in vivo assay for evaluating angiogenesis. By using standardized slow-release pellets containing specific growth factors that trigger blood vessel growth throughout the naturally avascular cornea, angiogenesis can be measured and quantified. In this assay the angiogenic response is generated over the course of several days, depending on the type and dose of growth factor used. The induction of neovascularization is commonly triggered by either basic fibroblast growth factor (bFGF) or vascular endothelial growth factor (VEGF). By combining these growth factors with sucralfate and hydron (poly-HEMA (poly(2-hydroxyethyl methacrylate))) and casting the mixture into pellets, they can be surgically implanted in the mouse eye. These uniform pellets slowly-release the growth factors over five or six days (bFGF or VEGF respectively) enabling sufficient angiogenic response required for vessel area quantification using a slit lamp. This assay can be used for different applications, including the evaluation of angiogenic modulator drugs or treatments as well as comparison between different genetic backgrounds affecting angiogenesis. A skilled investigator after practicing this assay can implant a pellet in less than 5 min per eye.

Citing Articles

ENO2-Regulated Glycolysis in Endothelial Cells Contributes to FGF2-Induced Retinal Neovascularization.

Liao D, Wang J, Zhang X, Li R, Yang X Invest Ophthalmol Vis Sci. 2025; 66(1):58.

PMID: 39854009 PMC: 11761142. DOI: 10.1167/iovs.66.1.58.

Endothelial FOXM1 and Dab2 promote diabetic wound healing.

Bhattacharjee S, Gao J, Lu Y, Eisa-Beygi S, Wu H, Li K JCI Insight. 2025; 10(2).

PMID: 39846251 PMC: 11790024. DOI: 10.1172/jci.insight.186504.

Interplay Between FoxM1 and Dab2 Promotes Endothelial Cell Responses in Diabetic Wound Healing.

Bhattacharjee S, Gao J, Lu Y, Eisa-Beygi S, Wu H, Li K bioRxiv. 2024; .

PMID: 39253510 PMC: 11383039. DOI: 10.1101/2024.02.07.579019.

Tumoroids, a valid preclinical screening platform for monitoring cancer angiogenesis.

Abbasi-Malati Z, Khanicheragh P, Narmi M, Mardi N, Khosrowshahi N, Hiradfar A Stem Cell Res Ther. 2024; 15(1):267.

PMID: 39183337 PMC: 11346257. DOI: 10.1186/s13287-024-03880-4.

Safety and tolerability of intravitreal umedaptanib pegol (anti-FGF2) for neovascular age-related macular degeneration (nAMD): a phase 1, open-label study.

Pereira D, Akita K, Bhisitkul R, Nishihata T, Ali Y, Nakamura E Eye (Lond). 2023; 38(6):1149-1154.

PMID: 38040965 PMC: 11009303. DOI: 10.1038/s41433-023-02849-6.

References

Rogers M, Birsner A, DAmato R . The mouse cornea micropocket angiogenesis assay. Nat Protoc. 2007; 2(10):2545-50. DOI: 10.1038/nprot.2007.368. View

Gimbrone Jr M, COTRAN R, Leapman S, Folkman J . Tumor growth and neovascularization: an experimental model using the rabbit cornea. J Natl Cancer Inst. 1974; 52(2):413-27. DOI: 10.1093/jnci/52.2.413. View

Calderone L, Grimes P, Shalev M . Acute reversible cataract induced by xylazine and by ketamine-xylazine anesthesia in rats and mice. Exp Eye Res. 1986; 42(4):331-7. DOI: 10.1016/0014-4835(86)90026-6. View

GOSPODAROWICZ D, Moran J, Braun D, Birdwell C . Clonal growth of bovine vascular endothelial cells: fibroblast growth factor as a survival agent. Proc Natl Acad Sci U S A. 1976; 73(11):4120-4. PMC: 431350. DOI: 10.1073/pnas.73.11.4120. View

Wong K, Chan J, Kamm R, Tien J . Microfluidic models of vascular functions. Annu Rev Biomed Eng. 2012; 14:205-30. DOI: 10.1146/annurev-bioeng-071811-150052. View

Gimbrone Jr M, Leapman S, COTRAN R, Folkman J . Tumor dormancy in vivo by prevention of neovascularization. J Exp Med. 1972; 136(2):261-76. PMC: 2139203. DOI: 10.1084/jem.136.2.261. View

Nicosia R, Tchao R, LEIGHTON J . Histotypic angiogenesis in vitro: light microscopic, ultrastructural, and radioautographic studies. In Vitro. 1982; 18(6):538-49. DOI: 10.1007/BF02810077. View

Rohan R, Fernandez A, Udagawa T, Yuan J, DAmato R . Genetic heterogeneity of angiogenesis in mice. FASEB J. 2000; 14(7):871-6. DOI: 10.1096/fasebj.14.7.871. View

Chang L, Garcia-Cardena G, Farnebo F, Fannon M, Chen E, Butterfield C . Dose-dependent response of FGF-2 for lymphangiogenesis. Proc Natl Acad Sci U S A. 2004; 101(32):11658-63. PMC: 511009. DOI: 10.1073/pnas.0404272101. View

10.

Kubota Y, Kleinman H, Martin G, Lawley T . Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol. 1988; 107(4):1589-98. PMC: 2115245. DOI: 10.1083/jcb.107.4.1589. View

11.

Montesano R, Orci L . Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell. 1985; 42(2):469-77. DOI: 10.1016/0092-8674(85)90104-7. View

12.

Korff T, Augustin H . Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J Cell Biol. 1998; 143(5):1341-52. PMC: 2133072. DOI: 10.1083/jcb.143.5.1341. View

13.

Udagawa T, Birsner A, Wood M, DAmato R . Chronic suppression of angiogenesis following radiation exposure is independent of hematopoietic reconstitution. Cancer Res. 2007; 67(5):2040-5. DOI: 10.1158/0008-5472.CAN-06-2877. View

14.

Glaser B, DAmore P, Seppa H, Seppa S, Schiffmann E . Adult tissues contain chemoattractants for vascular endothelial cells. Nature. 1980; 288(5790):483-4. DOI: 10.1038/288483a0. View

15.

Jain R, Schlenger K, Hockel M, Yuan F . Quantitative angiogenesis assays: progress and problems. Nat Med. 1997; 3(11):1203-8. DOI: 10.1038/nm1197-1203. View

16.

Turner P, Albassam M . Susceptibility of rats to corneal lesions after injectable anesthesia. Comp Med. 2005; 55(2):175-82. View